Prevention and treatment of HIV infections in minorities in the U.S. military: A review of military research

Military Medicine

Volumn 161, Issue 2, 1996, Pages 123-127

  Brown, Arthur E ^a   Newby, John H ^b   Ray, Karen L ^b   Jackson, James N ^b   Burke, Donald S ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b US Army Surg Gen's MHAG   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE; ZIDOVUDINE;

CONFERENCE PAPER; ETHNIC GROUP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFECTION RISK; MAJOR CLINICAL STUDY; MILITARY MEDICINE; NEGRO; SOLDIER; UNITED STATES;

EID: 0030052461     PISSN: 00264075     EISSN: None     Source Type: Journal    
DOI: 10.1093/milmed/161.2.123     Document Type: Conference Paper

References (17)

1. Renzullo PO, McNeil JG, Wann ZF, et al: Human immunodeficiency virus type-1 seroconversion trends among young adults serving in the United States Army, 1985-1993. J Acquir Immune Deflc Syndr 1995; 10: 177-85.
2. Cowan DN, Brundage JF, Pomerantz RS: The incidence of HIV infection among men in the United States Army reserve components, 1985-1991. AIDS 1994; 8: 505-11.
3. Gardner LI Jr, Brundage J, McNeil J, et al: Predictors of HIV-1 disease progression in early and late stage patients: the U S. Army Natural History Cohort. J Acquir Immune Defic Syndr 1992; 5: 782-93.
4. Burke DS, Fowler AK, Redfield RR, et al: Isolation of HIV-1 from the blood of seropositive adults: patient stage of illness and sample inoculum size are major determinants of a positive culture J Acquir Immune Defic Syndr 1990, 3: 1159-65.
5. Brown AE, Lane JR, Wagner KF, et al: Rates of p24 antigenemia and viral isolation in comparable white and black HIV-infected subjects. AIDS, 1995; 9: 325-8.
6. Vahey M, Birx DL, Michael NL, et al: Assessment of gag DNA and genomic RNA in peripheral blood mononuclear cells in HIV-infected patients receiving intervention with recombinant gp 160 subunit vaccine in a phase I study. AIDS Res Hum Retroviruses 1994; 10: 649-54.
7. Michael ML, Vahey M, Burke DS, et al Viral DNA and mRNA expression correlate with the stage of human immunodeficiency virus (HIV) type 1 infection in humans: evidence for viral replication in all stages of HIV disease. J Virol 1992; 66: 310-6.
8. Louwagle J, McCutchan FE, Peeters M, et al: Phylogenetic analysis of gag genes from 70 international HIV-1 isolates provides evidence for multiple genotypes. AIDS 1993; 7: 769-80.
9. Redfield RR, Birx DL, Ketter N, et al: A phase I evaluation of the safety and immunogenicity of vaccination with recombinant gp160 in patients with early HIV infection. N Engl J Med 1991; 324. 1677-84.
10. Biselli R, Loomis LD, Del Bono V, et al: Immunization of HIV-infected patients with RGP160. modulation of anti-RGP160 antibody spectrotype. J Acquir Immune Defic Syndr 1994; 7. 1016-24.
11. Hamilton JD, Hartigan PM, Simberkoff MS, et al A controlled trial of early versus late treatment with zidovudine in symptomatic human immunodeficiency virus infection. N Engl J Med 1932; 326: 437-68.
12. Concorde Coordinating Committee: Concorde. MRC/ANRS randomized double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection Lancet 1994, 346. 871-81.
13. Mayers DL, McCutchan FE, Sanders-Buell EE, et al: Characterization of HIV isolates arising after prolonged zidovudine therapy. J Acquir Immune Defic Syndr 1992; 5: 749-59.
14. Bjornson DC, Oster CN, Cortese LM, et al. Aerosolized pentamidme and Pneumocystis carinii pneumonia: patient compliance and outcomes. Ann Pharmacother 1992; 26: 1066-9.
15. Renzullo PO, McNeil JG, Levin LI, et al: Risk factors for prevalent human immunodeficiency virus (HIV) infection in active duty Army men who initially report no identified risk: a case-control study. J Acquir Immune Defic Syndr. 1990; 3: 266-71.
16. Levin LI, Peterman TA, Renzullo PO, et al: HIV-1 seroconversion and risk behaviors among young men in the US Army. Am J Public Health 1995; 85: 1500-6.
17. Blake SM, Sharp ES, Teinoshok LT, et al. Methodological considerations in developing measures of HIV risk-relevant behaviors and attitudes: an empirical illustration. Psychology & Health: An International Journal 1992; 6. 265-80